Wipfli Financial Advisors’s West Pharmaceutical WST Stock Holding History

Wipfli Financial Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$206K	Buy	+838	New	+$255K	0.01%	442

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wipfli Financial Advisors's WST Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in West Pharmaceutical (WST) in Q3 2022: 838 shares worth $206K. The stake represents 0.01% of the portfolio and ranks #442 among its holdings.

638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

Wipfli Financial Advisors held 838 shares of West Pharmaceutical worth $206K as of Q3 2022.
West Pharmaceutical was a new Wipfli Financial Advisors position in Q3 2022.
West Pharmaceutical made up 0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #442 holding.
638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.